Stena Sessan
VC Fund
Stockholm, Sweden
Stena Sessan is an investment company that focuses on businesses with the potential to develop and grow. The company's investment strategy is built on flexibility and a long-term investment horizon. It invests in strong businesses with great potential, where, through an active co-ownership, they help to develop businesses that can address theneeds and challenges that the future holds.ne of Stena Sessan’s most significant investments was a 21 percent ownership stake in Swedish pharmaceutical company, Meda, which was sold to US pharmaceutical company Mylan in August 2016 through a public takeover bid. At the time of the sale, Stena Sessan had been one of the company’s main owners for 18 years, and the deal was the second-largest sale of a company listed on the Stockholm Stock Exchange to date.In recent years, Stena Sessan has invested in Scandic Hotels, the largest hotel operator in the Nordic region. Stena Sessan is the largest shareholder in the company, with a 20% ownership stake.Stena Sessan was founded in 1981.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries Stena Sessan invests in
Stages Stena Sessan invests in
Countries Stena Sessan invests in
Round sizes
Contacts
Round size
- Series A
- $24M–$105M
- Series C
- $63M–$160M
Investment Focus
Industry
- Software 4 (21%)
- Analytics 3 (16%)
- SaaS 2 (11%)
- Health Care 2 (11%)
- Machine Learning 2 (11%)
Stage
- Series C 4 (21%)
- Funding Round 4 (21%)
- Series A 3 (16%)
- Seed 2 (11%)
- Post-IPO Equity 2 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Karl Swartling
CEO
|
CEO | Total investments: 0 | Find email | |
Kristina Patek
Senior Investment Director
|
Senior Investment Director | Total investments: 2 | Find email | |
Fredrik Konopik
Investment Director
|
Investment Director | Total investments: 2 | Find email | |
| CFO | Total investments: 0 | Find email | ||
| CFO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lassie
|
Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets | $75M / Series C / Feb 12, 2026 | |
VOI Technology
|
Voi is a micromobility company operating e-bikes and e-scooters in 150+ cities. EBIT-profitable since 2024. | $25M / Venture - Series Unknown / Mar 12, 2024 | |
Exeger
|
Exeger Sweden AB (formelry NLAB Solar) is a technology company that focuses on developing and commercializing light energy harvesting solutions. The company is known for its innovative technology that allows devices to convert ambient light into electrical energy, which can be used to power various electronic devices.Exeger's technology isoften applied in the manufacturing of solar cells, and the company aims to create sustainable and self-powered solutions for a variety of products, including consumer electronics, wearables, and other devices. The technology is designed to work efficiently even in indoor lighting conditions, making it suitable for a wide range of applications. | $38.2M / Series B / Dec 27, 2022 | |
Kognic
|
The analytics and annotation platform used to ensure the performance of perception systems part of autonomous vehicles. We are combining a modern data infrastructure with the safety requirements within the automotive to ensure your needs are covered in relation to developing and validating AD/ADAS functions. | $24M / Series A / Feb 03, 2022 | |
Kognic
|
Kognic provides the data platform accelerating ML for performance-critical applications. Our proven MLOps tools empower engineers to develop, test, and deploy perception systems in measurable and cost-efficient ways. | $24M / Series A / Feb 03, 2022 | |
A3P Biomedical
|
A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietaryalgorithm for the purpose of detecting aggressive prostate cancer at an early stage. | Jan 01, 2022 | |
|
VOI Technology
|
Voi is a micromobility company operating e-bikes and e-scooters in 150+ cities. EBIT-profitable since 2024. | $115M / Series D / Dec 20, 2021 | |
Funnel
|
Funnel is here to put an end to manual data collection. Funnel integrates with all marketing and advertising platforms and allows you to feed your data anywhere you want it. Out-of-the-box integrations with 400+ data sources.With Funnel, you will have the freedom to feed your data into any tool you like. Automatically feed data into your BusinessIntelligence tool, your Data Warehouse, Google Sheets, Google Data Studio, Google Analytics or any other visualization tool. Funnel caters to e-commerce companies, media agencies, brands, b2b businesses, mobile apps, and gaming companies. Fredrik Skantze and Per Made founded it in 2014. Offices in Stockholm (HQ) and Boston. | $65.8M / Series C / Oct 12, 2021 | |
Stegra
|
H2 Green Steel helps to build a large-scale steel factory based on a fossil-free manufacturing process targeting large European OEMs.The plant will be built in northern Sweden, in Boden, offering unique conditions for cost-competitive fossil-free steel production. The project includes a giga-scale green hydrogen plant as an integrated part of thesteel production facility. Production will begin in 2024 and by 2030, H2GS will have an annual production capacity of five million tons of high-quality steel. | $105M / Series A / May 24, 2021 | |
Doctor24
|
Doktor24, founded in 2016 and led by CEO Daniel Lillienau, developed a health network system by integrating digital and physical care service providing. The company also operates through a subsidiary, Platform24, which is a developer of technical solutions for digitally integrated care for both private and public healthcare providers. | $48.2M / Venture - Series Unknown / May 20, 2021 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Stena Sessan invest in?
Stena Sessan invests primarily in Software, Analytics and SaaS startups, most often at Series C and Funding Round stage. Most of the 19 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Stena Sessan's check size?
Stena Sessan typically joins rounds of $24M–$105M at Series A and $63M–$160M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Stena Sessan participates in.
How do I contact Stena Sessan?
Public channels for Stena Sessan include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Stena Sessan?
The team at Stena Sessan includes Karl Swartling (CEO), Kristina Patek (Senior Investment Director) and Fredrik Konopik (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
